Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease.
Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease.
复制标题
DOI:
10.1016/j.jalz.2018.03.005
复制
发表时间:
2018-08
期刊:
影响因子:
--
通讯作者:
Abdalla N
中科院分区:
文献类型:
--
作者:
Brookmeyer R;Abdalla N
Lifetime risks are the probabilities of progressing to AD dementia during ones’ lifespan. Here we report the first estimates of the lifetime and ten-year risks of AD dementia that account for age, gender and biomarker tests for preclinical disease. We used a multistate model for the disease process together with U.S. death rates. Lifetime risks of AD dementia vary considerably by age, gender and the pre-clinical or clinical disease state of the individual. For example, the lifetime risks for a female with only amyloidosis are 8.4% for a 90 year old and 29.3% for a 65 year old. Persons younger than age 85 with mild cognitive impairment, amyloidosis and neurodegeneration have lifetime risks of AD dementia greater than 50%. Most persons with preclinical AD will not develop AD dementia during their lifetimes. Lifetime risks help interpret the clinical significance of biomarker screening tests for AD.
登录
查看更多内容
DOI:
10.1016/j.jalz.2011.03.005
发表时间:
2011-05
期刊:
Alzheimer's & dementia : the journal of the Alzheimer's Association
影响因子:
--
作者:
McKhann GM;Knopman DS;Chertkow H;Hyman BT;Jack CR Jr;Kawas CH;Klunk WE;Koroshetz WJ;Manly JJ;Mayeux R;Mohs RC;Morris JC;Rossor MN;Scheltens P;Carrillo MC;Thies B;Weintraub S;Phelps CH
通讯作者:
Phelps CH
影响因子:
5.7
作者:
Langa, KM;Plassman, BL;Willis, RJ
通讯作者:
Willis, RJ
影响因子:
14
作者:
Brookmeyer, Ron;Johnson, Elizabeth;Arrighi, H. Michael
通讯作者:
Arrighi, H. Michael
影响因子:
9.9
作者:
James, Bryan D.;Leurgans, Sue E.;Bennett, David A.
通讯作者:
Bennett, David A.
影响因子:
120.7
作者:
Jansen, Willemijn J.;Ossenkoppele, Rik;Knol, Dirk L.;Tijms, Betty M.;Scheltens, Philip;Verhey, Frans R. J.;Visser, Pieter Jelle
通讯作者:
Visser, Pieter Jelle